NEUROCOGNICTION AND HIV

The introduction of highly active antiretroviral therapy has had a major impact on the treatment of human immunodeficiency virus (HIV) infection and has resulted in increased survival and a reduction in HIV-related dementia.

However, neurocognitive impairments in various neurocognitive domains remain common, occurring in 50% or more of HIV patients according to recent estimates. Increased life expectancy leads to the appearance of complicating factors, including cerebrovascular disease, neurotoxicity, aging, drug abuse, hepatitis. This article reviews the history of HIV-related neurocognitive impairment, impairments in various domains of neurocognition, and screening for neurocognitive impairment.

The introduction of highly active antiretroviral therapy has an enormous impact on the treatment of human immunodeficiency virus (HIV) infection and leads to increased survival and reduction of HIV-related dementia. However, neurocognitive impairments in various neurocognitive domains remain frequent, they occur in 50% or more of patients with HIV, according to recent estimates. Increased longevity adjusted to the emergence of complicating factors, including cerebrovascular disease, neurotoxicity, aging, substance abuse, hepatitis. This article discusses the history of HIV-associated neurocognitive disorder offenses in the various domains of neurocognition and screening of neurocognitive disorders.